Sentence: In the NALA trial , neratinib plus capecitabine led to increased PFS and time to intervention for central nervous system disease over the standard regimen of lapatinib plus capecitabine .
Drug combination annotation:
[{'class': 'POS', 'spans': ['neratinib', 'capecitabine'], 'is_context_needed': False}, {'class': 'POS', 'spans': [2, 3], 'is_context_needed': False}]